Enhanced Pain Relief and Function Improvement in Children with Osgood-Schlatter Disease: Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) as a Complementary Treatment to Standard Conservative Therapy

18 December 2023: Clinical Research

Tomasz Guszczyn ^1ABDEF* , Monika Kulesza ^2BCDEF , Aleksandra Kicman ^3CF , Joanna Motyka ^2CF , Sławomir Ławicki ^2AEG

DOI: 10.12659/MSM.941523

Med Sci Monit 2023; 29:e941523

Table 5 Summary of patient satisfaction and return to activity according to treatment before PRP (Platelet-Rich Plasma) injection.

Conservative type of treatment	Treatment satisfaction (%)	p*	Return to full physical activity (%)	p*
No treatment	44.4%	0.003*	44.4%	0.009*
Immobilization	50.00%	p	52.9%	0.008*
No immobilization	82.2%	p	78.0%	0.008*
Rehabilitation	95.7%	p	89.1%	p
No rehabilitation	43.3%	p	46.7%	p
Cessation of physical activity	81.1%	0.033*	77.9%	0.061
No cessation of physical activity	64.9%	0.033*	63.2%	0.061